Lisata Therapeutics (NASDAQ:LSTA) Given “Buy” Rating at HC Wainwright
HC Wainwright reaffirmed their buy rating on shares of Lisata Therapeutics (NASDAQ:LSTA – Free Report) in a research report sent to investors on Thursday morning,Benzinga reports. HC Wainwright currently has a $15.00 target price on the stock. Lisata Therapeutics Trading Down 3.1 % Shares of LSTA stock traded down $0.09 on Thursday, reaching $2.84. The […]
More Stories
Donaldson Company, Inc. (NYSE:DCI) Declares Quarterly Dividend of $0.27
Donaldson Company, Inc. (NYSE:DCI – Get Free Report) announced a quarterly dividend on Friday, November 22nd,RTT News reports. Stockholders of...
Lithium Americas (Argentina) (NYSE:LAAC) Stock Price Down 3.6% – Here’s What Happened
Lithium Americas (Argentina) Corp. (NYSE:LAAC – Get Free Report)’s share price dropped 3.6% on Friday . The company traded as...
Zevra Therapeutics (NASDAQ:ZVRA) Sets New 1-Year High – Here’s What Happened
Zevra Therapeutics, Inc. (NASDAQ:ZVRA – Get Free Report) shares hit a new 52-week high during mid-day trading on Friday ....
iShares iBonds Dec 2032 Term Corporate ETF (NYSEARCA:IBDX) Sees Unusually-High Trading Volume – Should You Buy?
Shares of iShares iBonds Dec 2032 Term Corporate ETF (NYSEARCA:IBDX – Get Free Report) saw unusually-strong trading volume on Friday...
Solid State (LON:SOLI) Trading 10.6% Higher – Should You Buy?
Solid State plc (LON:SOLI – Get Free Report)’s stock price was up 10.6% on Friday . The stock traded as...
Symbotic (NASDAQ:SYM) Shares Up 9.2% – Still a Buy?
Symbotic Inc. (NASDAQ:SYM – Get Free Report)’s stock price rose 9.2% on Friday . The company traded as high as...